TP53 and cancer: To perform a comparative activation of p53 target genes with PG3 and PG3-Oc, five cancer cell lines with conformation p53-R175H mutation (TOV-112D), contact p53-R273H mutation (HT29), and an isogenic HCT116 cell line with wild-type p53, p53-null and p53-R175H were selected.